Healthcare Sector

PTCT

Market Tracker

  • PTCT (Selected)

    PTC Therapeutics, Inc.

PTCT Most Active Options Strike Prices Whale BUY Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.

PTCT Most Active Options Strike Prices Whale SALES Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.

PTCT Open Interest Trend

Loading Data..

Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.

PTCT Largest 1-Day Open Interest Movements

Expires Type Strike OI Change Percent
03/20/2026 CALL $75.00 10 +1 +11.11%
02/20/2026 CALL $50.00 0 0
02/20/2026 CALL $55.00 0 0
02/20/2026 CALL $60.00 0 0
02/20/2026 CALL $65.00 0 0
02/20/2026 CALL $70.00 20 0
01/21/2028 PUT $95.00 0 0
01/21/2028 PUT $100.00 0 0
01/21/2028 PUT $105.00 0 0
01/21/2028 PUT $110.00 0 0
01/21/2028 PUT $115.00 0 0
02/20/2026 CALL $75.00 141 -1 -0.70%

Contracts with largest changes in open interest from the previous trading day to the current/most recent.

PTCT Major Holders

Name Pct Held Shares Total
Vanguard Total Stock Market Index Fund 2.96% 2.18M 87.61M
Vanguard Small-Cap Index Fund 2.51% 1.85M 74.35M
SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF 2.45% 1.81M 72.62M
Fidelity Select Portfolios - Biotechnology 2.20% 1.62M 65.1M
iShares Russell 2000 ETF 2.09% 1.55M 62.06M
Hartford Mid Cap Fund 1.90% 1.4M 56.17M
Vanguard Specialized-Health Care Fund 1.67% 1.24M 49.62M
Delaware Group Equity Fds V-Small Cap Core Fund 1.48% 1.1M 43.98M
Vanguard Small-Cap Growth Index Fund 1.45% 1.07M 42.97M
Vanguard Extended Market Index Fund 1.32% 976.77k 39.22M

PTCT News

  • What's Going On With Royalty Pharma Stock Wednesday?

    12/31 11:47 am

    Benzinga

    Read more
  • Royalty Pharma Acquires Remaining Royalty Interest in Roche's Evrysdi for $240 Million and Potential Milestones

    12/29 05:40 pm

    Benzinga

    Read more
  • Here's Why Shares in PTC Therapeutics Soared This Week

    09/05 08:35 am

    The Motley Fool

    Read more
  • Novartis reports strong Q2 with double-digit sales growth and core margin expansion; raises FY 2025 core operating income guidance

    07/17 01:00 am

    GlobeNewswire Inc.

    Read more
  • INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc. - CAPR

    06/02 01:55 pm

    GlobeNewswire Inc.

    Read more
  • INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc. - PTCT

    06/02 01:52 pm

    GlobeNewswire Inc.

    Read more
  • Evolving Landscape of Mitochondrial Disease Market: Key Insights of Latest Published Report—Leigh Syndrome, Leber’s Hereditary Optic Neuropathy, MELAS Syndrome, and Thymidine Kinase 2 Deficiency | DelveInsight

    05/26 01:00 pm

    GlobeNewswire Inc.

    Read more
  • SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc. - PTCT

    08/03 03:41 pm

    GlobeNewswire Inc.

    Read more
  • PTC Therapeutics, Inc. (PTCT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek ... - GlobeNewswire

    07/09 02:01 pm

    GlobeNewswire Inc.

    Read more
  • PTC Therapeutics (PTCT) Down on Negative CHMP Opinion on DMD Drug

    07/01 08:00 am

    Zacks Investment Research

    Read more
  • PTC Therapeutics (PTCT) Soars 9.7%: Is Further Upside Left in the Stock?

    06/24 04:44 am

    Zacks Investment Research

    Read more
  • The Zacks Analyst Blog Highlights Biogen, Ionis Pharmaceuticals, GSK, PTC Therapeutics and Larimar Therapeutics

    05/24 09:38 am

    Zacks Investment Research

    Read more
  • Biotech Stock Roundup: BIIB's Acquisition, PTCT, LRMR Gain on Updates & More News

    05/23 12:46 pm

    Zacks Investment Research

    Read more
  • PTC Therapeutics (PTCT) Up as EC Returns CHMP Opinion on DMD Drug

    05/21 12:26 pm

    Zacks Investment Research

    Read more
  • Compared to Estimates, PTC Therapeutics (PTCT) Q1 Earnings: A Look at Key Metrics

    04/25 08:00 pm

    Zacks Investment Research

    Read more
  • PTC Therapeutics (PTCT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

    04/18 10:01 am

    Zacks Investment Research

    Read more
  • Biotech Stock Roundup: GERN, CRNX Gain on Updates, BMY's CAR T Cell Therapy News & More

    03/21 10:01 am

    Zacks Investment Research

    Read more
  • PTC Therapeutics (PTCT) Up on Positive Regulatory Updates

    03/20 02:00 pm

    Zacks Investment Research

    Read more
  • Cooper Companies Reports Upbeat Results, Joins Dell, NetApp, Tidewater And Other Big Stocks Moving Higher On Friday

    03/01 12:18 pm

    Benzinga

    Read more
  • Here's What Key Metrics Tell Us About PTC Therapeutics (PTCT) Q4 Earnings

    02/29 07:00 pm

    Zacks Investment Research

    Read more
  • PTC Therapeutics (PTCT) Reports Q4 Loss, Lags Revenue Estimates

    02/29 06:20 pm

    Zacks Investment Research

    Read more
  • Wall Street's Insights Into Key Metrics Ahead of PTC Therapeutics (PTCT) Q4 Earnings

    02/26 10:16 am

    Zacks Investment Research

    Read more
  • Will Karyopharm Therapeutics (KPTI) Report Negative Q4 Earnings? What You Should Know

    02/14 11:00 am

    Zacks Investment Research

    Read more
  • PTC Therapeutics (PTCT) to Report Q4 Results: Wall Street Expects Earnings Growth

    02/13 11:00 am

    Zacks Investment Research

    Read more
  • 1 of Sarepta Therapeutics' Competitors Just Got Hammered. Will It Help the Stock?

    02/11 02:45 am

    The Motley Fool

    Read more
  • Strength Seen in Enanta Pharmaceuticals (ENTA): Can Its 13.8% Jump Turn into More Strength?

    01/05 04:09 am

    Zacks Investment Research

    Read more
  • Biogen's (BIIB) Rare Disease Drug Skyclarys Gets CHMP Nod in EU

    12/18 10:57 am

    Zacks Investment Research

    Read more
  • Solid Biosciences' (SLDB) DMD Drug Gets Fast Track Tag, Stock Up

    12/08 06:37 am

    Zacks Investment Research

    Read more
  • Entrada (TRDA) Down on FDA Maintaining Clinical Hold on DMD Drug

    11/23 12:47 pm

    Zacks Investment Research

    Read more
  • Analyst Expectations for PTC Therapeutics's Future

    11/20 11:00 am

    Benzinga

    Read more
  • Solid Biosciences (SLDB) Stock Up as FDA Clears DMD Drug IND

    11/16 09:29 am

    Zacks Investment Research

    Read more
  • Pinterest Primed for Rich Ad Spend; Adobe a Powerhouse: Street Calls of the Week

    10/29 09:46 am

    Investing.com

    Read more
  • Amazon To Rally Around 55%? Here Are 10 Top Analyst Forecasts For Friday

    10/27 08:06 am

    Benzinga

    Read more
  • The Zacks Analyst Blog Highlights Bristol Myers, PTC Therapeutics, Beam Therapeutics and BioMarin Pharmaceutical

    10/27 07:15 am

    Zacks Investment Research

    Read more
  • PTC Therapeutics (PTCT) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

    10/26 07:30 pm

    Zacks Investment Research

    Read more
  • PTC Therapeutics (PTCT) Reports Q3 Loss, Lags Revenue Estimates

    10/26 05:30 pm

    Zacks Investment Research

    Read more
  • Biotech Stock Roundup: BMY's Q3 Results, PTCT Up on Deal, BEAM's Restructuring News

    10/26 11:28 am

    Zacks Investment Research

    Read more
  • Neurocrine Biosciences (NBIX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

    10/24 10:00 am

    Zacks Investment Research

    Read more
  • Why PTC Therapeutics Soared 15% Higher Today

    10/19 07:02 pm

    The Motley Fool

    Read more
  • Nasdaq Falls 100 Points; AT&T Posts Upbeat Earnings

    10/19 02:37 pm

    Benzinga

    Read more
  • Why Nokia Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

    10/19 01:52 pm

    Benzinga

    Read more
  • PTC Therapeutics (PTCT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

    10/19 10:01 am

    Zacks Investment Research

    Read more
  • AT&T, Union Pacific, Las Vegas Sands And Other Big Stocks Moving Higher On Thursday

    10/19 09:56 am

    Benzinga

    Read more
  • PTC Therapeutics stock jumps on royalty deal worth up to $1.5 billion

    10/19 09:18 am

    MarketWatch

    Read more
  • PTC Therapeutics (PTCT) Moves 5.3% Higher: Will This Strength Last?

    10/11 08:07 am

    Zacks Investment Research

    Read more
  • Benzinga's Top Ratings Upgrades, Downgrades For October 6, 2023

    10/06 11:00 am

    Benzinga

    Read more
  • PTC Therapeutics (PTCT) to Cut 25% Jobs by January 2024

    09/29 11:18 am

    Zacks Investment Research

    Read more
  • Biotech Stock Roundup: GSK's Drug Approval, MRNA's Vaccine News, PTCT & SPRY Down

    09/21 10:43 am

    Zacks Investment Research

    Read more
  • PTC Therapeutics (PTCT) Surges 5.8%: Is This an Indication of Further Gains?

    09/20 04:00 am

    Zacks Investment Research

    Read more
👀

Follow the Whales in real-time.

🎁

Take 50% OFF With Code: